This ORS effervescent tablet has been developed according to the latest guidelines of the WHO. We are looking for partners in Europe and in other areas to commercialize the ORS effervescent tablets More
Kortos® Cream contains anti-inflammatory-antipruritic-vasoconstrictor, astringent, antiseptic and local anesthetic in a special water repellant base. More
CIP-FENOFIBRATE is a novel oral formulation of Fenofibrate capsules that has been developed using new proprietary, superbioavailable drug delivery technology referred to as Lidose®. More
A new veterinary medicinal composition designed to maintain the oxygenic consumption, to restore hydric, electrolytic and energetic status, as well as the blood pH in affected mammals. More
Use of depth filters to remove prion infectivity from plasma - derived therapeutic products and/or other biologics. Depth Filtration is a chemically inactive process and therefore does not introduce potentially toxic bi-products or alter components. More
Displaying 1..10 of 19 -
per page
Next page
Order by